Genentech News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.11.08	Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival in Advanced Breast Cancer (Businesswire)
14.10.08	Genentech Announces Third Quarter 2008 Results (Businesswire)
16.05.08	Genentech Provides Update on Studies of Investigational Biooncology Agents to Be Presented at the American Society of Clinical Oncology Meeting (Businesswire)
14.03.08	Seven Summits Research Releases Comments on C, DNA, CX, ANN, and ACH (PR Newswire)
15.10.07	Genentech Announces Third Quarter 2007 Results (Businesswire)
02.08.07	CORRECTING and REPLACING Genentech Announces Expiration of Hart-Scott-Rodino Waiting Period and Completes Acquisition of Tanox (Businesswire)
04.06.07	Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer (Businesswire)
04.04.07	BIOCOM Announces New Board Members (PR Newswire)
14.02.07	Genentech Announces Additional Effort to Support Patient Access (PR Newswire)
02.02.07	Genentech Announces Positive Results from a Phase IV Study of Raptiva in Patients With Moderate-to-Severe Hand and Foot Psoriasis (PR Newswire)
17.01.07	Genentech Announces Senior Vice President and Vice President Promotions in Commercial, Legal and Product Operations (PR Newswire)
11.01.07	Seven Summits Research Releases Alerts on AMZN, DNA, DO, NVDA, and CY (PR Newswire)
10.01.07	Genentech Announces Full Year and Fourth Quarter 2006 Results (PR Newswire)
04.01.07	Genentech Announces Positive Results From a Randomized Phase II Study of Pertuzumab in Combination With Gemcitabine for Advanced Ovarian Cancer (PR Newswire)
13.12.06	New England Journal of Medicine Publishes Data from Pivotal Study of Avastin Plus Chemotherapy in Most Common Type of Lung Cancer (PR Newswire)
12.11.06	Subsequent Course of Rituxan(R) Improved Outcomes in Rheumatoid Arthritis Patients Who Inadequately Responded to TNF Antagonist Therapy (PR Newswire)
09.11.06	Genentech Announces Agreement to Acquire Tanox for $20 Per Share (PR Newswire)
11.08.06	Genentech Provides Update on Supplemental Biologics License Application for Adjuvant Herceptin(R) in Early-Stage HER2-Positive Breast Cancer (PR Newswire)
11.04.06	Genentech Announces First Quarter 2006 Results (PR Newswire)
01.03.06	Genentech Granted Six-Month Priority Review for Lucentis for the Treatment of Wet Age-Related Macular Degeneration (PR Newswire)
13.02.06	Recruitment Temporarily Suspended in an International Phase III Trial (AVANT) in Early-Stage Colon Cancer (PR Newswire)
10.01.06	Genentech Announces Full Year and Fourth Quarter 2005 Results (PR Newswire)
05.01.06	Genentech Announces Executive Promotions (PR Newswire)
19.12.05	Genentech Submits Supplemental Biologics License Application for Avastin(R) in Relapsed Metastatic Colorectal Cancer (PR Newswire)
31.10.05	Biogen Idec and Genentech Announce FDA Acceptance of Supplemental Biologics License Application and Priority Review Designation for Rituxan(R) in Rheumatoid Arthritis (PR Newswire)
18.10.05	Genentech Announces Preliminary Results From Randomized Phase II Trial of Avastin and Tarceva in Kidney Cancer (PR Newswire)
28.06.05	Genentech Announces Vice President Appointments in Product Operations, Regulatory, and Research (PR Newswire)
28.06.05	Genentech Announces Vice President Appointments in Product Operations, Regulatory, and Research (PR Newswire)
15.05.05	Data From Omnitarg Clinical Program Presented at American Society of Clinical Oncology Meeting (PR Newswire)
14.05.05	Avastin Plus Chemotherapy Showed Doubling of Time Without Cancer Progression In Phase III Trial of First-Line Metastatic Breast Cancer Patients (PR Newswire)
13.05.05	Herceptin Plus Chemotherapy Improved Disease-Free Survival and Overall Survival in Adjuvant Setting for Early-Stage HER2-Positive Breast Cancer Patients (PR Newswire)
02.05.05	OSI Pharmaceuticals and Genentech Announce Filing of a Supplemental Ne (Businesswire)
15.04.05	Interim Analysis of Phase III Trial Shows Avastin Plus Chemotherapy Im (PR Newswire)
21.03.05	Genentech and Ipsen Agree to Develop Sustained-Release Formulations of (PR Newswire)
14.03.05	Interim Analysis of Phase III Trial Shows Avastin Plus Chemotherapy Ex (PR Newswire)
27.01.05	Data from Phase III Study Show Tarceva Plus Gemcitabine Significantly (Businesswire)
12.01.05	MORNING UPDATE: Man Securities Inc. Issues Alerts for HPQ, DNA, SAP, N (PR Newswire)
10.01.05	Genentech Announces Fourth Quarter and Full Year 2004 Results (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	291.70	1.21 %	K V
CieFinRichemont	180.55	0.87 %	K V
Nestle	78.78	0.74 %	K V
Givaudan	3’845.00	0.42 %	K V
Geberit	513.40	0.31 %	K V
Kuehne+Nagel Int	207.70	-0.86 %	K V
UBS Group	30.02	-0.92 %	K V
Sonova Hldg	302.60	-1.01 %	K V
Alcon	80.84	-1.56 %	K V
Lonza Grp	598.60	-1.68 %	K V

mehr

21.09.23		Roche-Aktie gibt ab: Roche-Tochter Genentech offenbar mit Erfolg vor US-Berufungsgericht
12.07.22		Roche-Tochter Genentech erweitert Onkologie-Zusammenarbeit mit Bicycle - Roche-Aktie höher
27.05.22		Roche-Aktie schliesst dennoch tiefer: Roche-Tochter Genentech mit positiven Daten zu Antikörper Glofitamab
01.02.22		Roche- und Biogen-Aktien in Grün: Roche-Tochter Genentech kooperiert in Mosunetuzumab-Entwicklung mit Biogen
24.01.22		Roche-Tochter Genentech bestätigt Wirksamkeit von Augenmittel Faricimab - Roche-Aktie im Minus
25.02.21		Roche-Tochter Genentech veröffentlicht Evrysdi-Daten in Fachjournal
14.12.20		Roche-Aktie stabil: Genentech schliesst Lizenzabkommen mit Relay für Krebskandidaten
06.10.20		Roche-Tochter Genentech geht Partnerschaft mit Imbio zu Bildgebungsverfahren ein

21.09.23

Roche-Aktie gibt ab: Roche-Tochter Genentech offenbar mit Erfolg vor US-Berufungsgericht

12.07.22

Roche-Tochter Genentech erweitert Onkologie-Zusammenarbeit mit Bicycle - Roche-Aktie höher

27.05.22

Roche-Aktie schliesst dennoch tiefer: Roche-Tochter Genentech mit positiven Daten zu Antikörper Glofitamab

01.02.22

Roche- und Biogen-Aktien in Grün: Roche-Tochter Genentech kooperiert in Mosunetuzumab-Entwicklung mit Biogen

24.01.22

Roche-Tochter Genentech bestätigt Wirksamkeit von Augenmittel Faricimab - Roche-Aktie im Minus

25.02.21

Roche-Tochter Genentech veröffentlicht Evrysdi-Daten in Fachjournal